Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes

Journal of Lipid Research

Volumn 37, Issue 9, 1996, Pages 1886-1896

  Li, Zhengling ^a   McNamara, Judith R ^a   Fruchart, Jean Charles ^b   Luc, Gerald ^b   Bard, Jean M ^b   Ordovas, Jose M ^a   Wilson, Peter W F ^c   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

apolipoproteins; lipids; lipoprotein particle title sizes; lipoprotein subspecies; menopause

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; PARTICLE SIZE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEINS; CLIMACTERIC; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MENOPAUSE; MIDDLE AGED; MODELS, STATISTICAL; POSTMENOPAUSE; PREMENOPAUSE; REGRESSION ANALYSIS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 0029820904     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Kannel, W. B., and T. J. Thom. 1986. Incidence, prevalence, and mortality of cardiovascular disease. In The Heart. J. W. Hurst, editor. Sixth edition. McGraw-Hill, New York, NY. 557-565.
2. The Expert Panel. 1993. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) J. Am. Med. Assoc. 269: 3015-3023.
3. Castelli, W. P., R. J. Garrison, P. W. F. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Heart Study. J. Am. Med. Assoc. 256: 2835-2838.
4. Kannel, W. B., J. D. Neaton, H. E. Thomas, J. Stamler, S. D. Hulley, and M. O. Kjelsberg. 1986. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am. Heart J. 112: 825-836.
5. Miller, G. J., and N. E. Miller. 1975. Plasma high-density lipoprotein concentration and development of ischaemic heart disease. Lancet, i: 16-19.
6. Anderson, K. M., W. P. Castelli, and D. Levy. 1989. Cholesterol and normality: 30 years of follow up from the Framingham Heart Study. J. Am. Med. Assoc. 257: 2176-2180.
7. Heiss, G., T. Tamir, C. E. Davis, H. A. Tyroler, B. M. Rifkind, G. Schonfeld, D.Jacobs, and I. D. Frantz, Jr. 1988. Lipoprotein cholesterol distributions in selected North American populations: the Lipid Research Clinics Program prevalence study. Circulation. 61: 302-315.
8. Gillmer, M. D. 1992. Mechanism of action/effects of androgens on lipid metabolism. Int. J. Fertility. 37 Suppl (2): 83-92.
9. Brown, S. A., R. Hutchinson, J. Morrisett, E. Boerwinkle, C. E. Davis, A. M. Gotto, Jr., and W. Patsch. 1993. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. Arterioscler. Thromb. 13: 1139-1158.
10. Stevenson, J. C., D. Crook, and I. F. Godsland. 1993. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 98: 83-90.
11. Razay, G., K. W. Heaton, and C. H. Bolton. 1992. Coronary heart disease risk factors in relation to the menopause. Q. J. Med. 85(307-308): 889-896.
12. Krauss, R. M., and A. V. Nichols. 1986. Metabolic interrelationships of HDL subclasses. Adv. Exp. Med. Biol. 201: 17-27.
13. Blanche, P. J., E. L. Gong, T. M. Forte, and A. V. Nichols. 1981. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665: 408-419.
14. Li, Z., J. R. McNamara, J. M. Ordovas, and E. J. Schaefer. 1994. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J. Lipid Res. 35: 1698-1711.
15. McNamara, J. R., H. Campos, J. M. Ordovas, J. Peterson, P. W. F. Wilson, and E. J. Schaefer. 1987. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis. 7: 483-490.
16. Campos, H., E. Blijlevens, J. R. McNamara, J. M. Ordovas, B. M. Posner, P. W. F. Wilson, W. P. Castelli, and E. J. Schaefer. 1992. LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler. Thromb. 12: 1410-1419.
17. Cheung, M. C., and J. J. Albers. 1984. Characterization of lipoprotein particles isolated by immunoaffinity chromatography particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259: 12201-12209.
18. Parra, H. J., H. Mezdour, N. Ghalim, J. M. Bard, and J. C. Fruchart. 1990. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready to use plates. Clin. Chem. 36: 1431-1435.
19. Parra, H. J., D. Arveiler, A. E. Evans, J. P. Cambou, P. Amouyel, A. Bingham, D. McMaster, P. Schaffer, P. Douste-Blazy, G. Luc, J. L. Richard, P. Ducimetiere, J. C. Fruchart, and F. Cambien. 1992. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary artery disease: the ECTIM study. Arterioscler. Thromb. 12: 701-707.
20. Williams, P. T., R. M. Krauss, K. M. Vranizan, M. L. Stefanick, P. D. S. Wood, and F. T. Lindgren. 1992. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler. Thromb. 12: 332-340.
21. Campos, H., J. Genest, Jr., J. M. Ordovas, J. R. McNamara, J. Jenner, E. Biljevens, P. W. F. Wilson, and E. J. Schaefer. 1992. Low density lipoprotein particle size and coronary artery disease in men. Arterioscler. Thromb. 12: 187-195.
22. Kandoussi, A., C. Cachera, D. Parsy, J. M. Bard, and J-C. Fruchart. 1991. Quantitative determination of different apolipoprotein B-containing lipoproteins by an enzyme-linked immunosorbent assay: apoB with apoC-III and apoB with apoE. J. Immunoassay. 12: 305-323.
23. Johansson, J., L. A. Carlson, C. Landou, and A. Hamsten. 1991. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler. Thromb. 11: 174-182.
24. Cheung, M. C., B. G. Brown, A. C. Wolf, and J. J. Albers. 1991. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J. Lipid Res. 32: 383-394.
25. Syvanne, M., M. Ahola, S. Lahdenpera, J. Kahri, T. Kuusi, K. S. Virtanen, and M. R. Taskinen. 1995. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J. Lipid Res. 36: 573-582.
26. McNamara, J. R., T. G. Cole, J. H. Contois, C.A. Ferguson, J. M. Ordovas, and E. J. Schaefer. 1995. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin. Chem. 41: 232-240.
27. Alaupovic, P. 1982. The role of apolipoproteins in lipid transport processes. Ric. Clin. Lab. 12: 3-21.
28. Puchois, P., A. Kandoussi, P. Fievet, J. L. Fourrier, M. Bertrand, E. Koren, and J. C. Fruchart. 1987. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 68: 35-40.
29. Genest, J., Jr., J. M. Bard, J-C. Fruchart, J. M. Ordovas, P. W. F. Wilson, and E. J. Schaefer. 1991. Plasma apolipoprotein A-I, A-II, B and C-III containing particles in men with premature coronary artery disease. Atherosclerosis. 90: 149-157.
30. Kannel, W. B., M. Feinleib, P. M. McNamara, R. Garrison, and W. Castelli. 1979. An investigation of coronary heart disease in families. The Framingham Offspring Study. Am. J. Epidemiol 110: 281-290.
31. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
32. McNamara, J. R., and E. J. Schaefer. 1987. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta. 166: 1-8.
33. Schaefer, E. J., and J. M. Ordovas. 1986. Metabolism of apolipoproteins A-I, A-II, and A-IV. Methods Enzymol. 129: 420-443.
34. Ordovas, J. M., J. P. Peterson, P. Santaniello, J. S. Cohn, P. W. F. Wilson, and E. J. Schaefer. 1987. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J. Lipid Res. 28: 1216-1224.
35. Rosseneu, M., G. Michiels, W. De Keersgieter, J. Bury, J. P. De Slypere, H. Dieplinger, and G. Utermann. 1988. Quantification of human apolipoprotein A-IV by "sandwich-type" enzyme-linked immunosorbent assay. Clin. Chem. 34: 739-743.
36. Curry, M. D., W. J. McConathy, J. D. Fesmire, and P. Alaupovic. 1988. Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim. Biophys. Acta. 617: 503-513.
37. Fruchart, J. C., C. Fievet, and P. Puchois. 1985. Apolipoproteins. Metabolites III: lipids, amino acids and related compounds. In Methods of Enzymatic Analysis. H. U. Bergmeyer, editor. Verlag Chemie Publications, New York, NY. 126-128.
38. Koffigan, M., I. Kora, V. Clavey, J. M. Bard, J. Chapman, and J. C. Fruchart. 1987. Quantification of human apolipoprotein E in plasma and lipoprotein subfractions by a non-competitive enzymatic immunoassay. Clin. Chim. Acta. 163: 245-256.
39. Bard, J. M., L. Candelier, G. Agnani, V. Clavey, G. Torpier, A. Steinmetz, and J. C. Fruchart. 1991. Isolation and characterization of human LpB lipoprotein containing apolipoprotein B as the sole apolipoprotein. Biochim. Biophys. Acta. 1082: 170-176.
40. McNamara, J. R., D. M. Small, Z. Li, and E. J. Schaefer. 1996. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J. Lipid Res. 37: 1924-1935.
41. Krauss, R. M., and P. J. Blanche. 1992. Detection and quantitation of LDL subfractions. Curr. Opin. Lipidol. 3: 377-383.
42. Schaefer, E. J., S. Lamon-Fava, S. D. Cohn, M. M. Schaefer, J. M. Ordovas, W. P. Castelli, and P. W. F. Wilson. 1994. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 35: 779-792.
43. Kannel, W. B., M. C. Hjortland, P. M. McNamara, and T. Gordon. 1976. Menopause and risk of cardiovascular disease. The Framingham Study. Ann. Intern. Med. 85: 447-452.
44. Stampfer, M. J., G. A. Colditz, W. C. Willett, J. E. Manson, B. Rosner, F. E. Speizer, and C. H. Hennekens. 1991. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325: 756-762.
45. Lerner, D. J., and W. Kannel. 1986. Pattern of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 111: 383-390.
46. Vermaak, W. J., J. P. Kotze, A. M. van der Merwe, P. J. Becker, J. B. Ubbink, H. C. Barnard, F. G. Roux, J. J. Schoeman, and C. L. Strydom. 1991. Epidemiological reference ranges for low-density lipoprotein cholesterol and apolipoprotein B for identification of increased risk of ischaemic heart disease. S. Afr. Med. J. 79: 367-371.
47. Fievet, C., M-C. Nuttens, P. Ducimetiere, J-C. Fruchart, M. Bertrand, and J-L. Salomez. 1991. Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies. Circulation. 84: 153-159.
48. Brunzell, J. D., A. D. Sniderman, J. J. Albers, and P. O. Kwiterovich, Jr. 1984. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 4: 191-205.
49. Krauss, R. M., and D. J. Burke. 1982. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid Res. 23: 97-104.
50. McNamara, J. R., J. L. Jenner, Z. Li, P. W. F. Wilson, and E. J. Schaefer. 1992. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler. Thromb. 12: 1284-1290.
51. Schaefer, E. J., L. A. Zech, L. L. Jenkins, R. A. Aamodt, T. J. Bronzert, E. A. Rubalcaba, F. T. Lindgren, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23: 850-862.
52. Schaefer, E. J., D. A. Foster, L. A. Zech, H. B. Brewer, Jr., and R.I. Levy. 1983. The effect of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 57: 262-270.
53. Brinton, E. A. 1996. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler. Thromb. Vasc. Biol. 16: 431-440.
54. Abbott, R. D., R. J. Garrison, P. W. F. Wilson, F. H. Epstein, W. P. Castelli, M. Feileib, and C. LaRue. 1983. Joint distribution of lipoprotein cholesterol classes. The Framingham Study. Arteriosclerosis. 3: 260-272.
55. Alaupovic, P., W. J. McConathy, J. Fesmire, M. Tavella, and J. M. Bard. 1988. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. Clin. Chem. 34/8(B): B13-B27.
56. Ericsson, S., M. Eriksson, S. Vitols, K. Einarsson, L. Berglund, and B. Angelin. 1991. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J. Clin. Invest. 87: 591-596.
57. Millar, J. S., A. H. Lichtenstein, M. Cuchel, G. G. Dolnikowski, D. L. Hachey, J. S. Cohn, and E.J. Schaefer. 1995. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. J. Lipid Res. 36: 1155-1167.
58. Barbaras, R., P. Grimaldi, R. Negrel, and G. Aihaud. 1985. Binding of lipoproteins and regulation of cholesterol synthesis in cultured mouse adipose cells. Biochim. Biophys. Acta. 845: 492-501.
59. Tikkanen, M., E. A. Nikkila, and E. Vartianen. 1978. Natural estrogen as an effective treatment for type-II hyperlipoproteinemia in postmenopausal women. Lancet. 2: 490-491.
60. Granfone, A., H. Campos, J. R. McNamara, M. M. Schaefer, S. Lamon-Fava, J. M. Ordovas, and E. J. Schaefer. 1992. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism. 41: 1193-1198.
61. Schaefer, E. J., R. I. Levy, D. W. Anderson, R. N. Danner, H. B. Brewer, Jr., and W. C. Blackwelder. 1978. Plasma triglycerides in regulation of HDL-cholesterol levels. Lancet. 2: 391-393.
62. Schaefer, E. J., S. Lamon-Fava, J. M. Ordovas, S. D. Cohn, M. M. Schaefer, W. P. Castelli, and P. W. F. Wilson. 1994. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J. Lipid Res. 35: 871-882.
63. Schaefer, E. J., C. B. Blum, R. I. Levy, L. L. Jenkins, P. Alaupovic, D. M. Foster, and H. B. Brewer, Jr. 1978. Metabolism of high density lipoprotein apolipoproteins in Tangier disease. N. Engl. J. Med. 299: 905-910.
64. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 387: 536-544.
65. Hayek, T., Y. Ito, N. Azrolan, R. B. Verdery, K. Aattosetala, A. Walsh, and J. L. Breslow. 1993. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo) A-I. Presentation of a new animal model and mechanistic studies in human apoA-I transgenic and control mice. J. Clin. Invest. 91: 166-1671.